Robotic prostatectomy in the era of multiple platforms: navigating complexity through decision-making algorithms [0.03%]
多平台时代的机器人前列腺切除术：通过决策算法解决复杂性问题
Riccardo Bertolo,Riccardo Campi,Lorenzo Bianchi et al.
Riccardo Bertolo et al.
HUGO™ RAS for radical nephroureterectomy: a new platform facing an old challenge [0.03%]
HUGO™ 机器人辅助根治性肾输尿管切除术：新平台应对老挑战
Andrea Mari,Simone Albisinni,Roberto Contieri et al.
Andrea Mari et al.
Artificial intelligence based real-time segmentation and feature tracking in urological retroperitoneal robotic assisted surgery [0.03%]
基于人工智能的实时分割和特征跟踪在泌尿外科后腹腔镜机器人辅助手术中的应用
Luca A Morgantini,Rebecca Canneto,Rogerio G Nespolo et al.
Luca A Morgantini et al.
Background: Robotic-assisted surgery, particularly with the da Vinci Single-Port system, enables precise operations in confined anatomical spaces like the retroperitoneum. However, the complexity of retroperitoneal anatom...
Bilateral ileal ureteral replacement with Y-shaped configuration for bilateral complex ureteral strictures: the initial dual-center experience [0.03%]
Y形双侧输尿管缺损回肠代 ure的初步两中心经验
Guanpeng Han,Xiang Wang,Zhihua Li et al.
Guanpeng Han et al.
Background: Bilateral complex ureteral strictures pose a significant challenge to all urologists. Conventional reconstructive techniques, such as oral mucosal grafts or Boari flap, have limited ability to repair extensive...
Multicenter Study
Minerva urology and nephrology. 2025 Dec;77(6):828-839. DOI:10.23736/S2724-6051.25.06574-7 2025
Exploring the influence of the bladder microbiome on BCG immunotherapy outcomes for high-risk non muscle invasive bladder cancer [0.03%]
探究膀胱菌群对高危非肌层浸润性膀胱癌BCG免疫治疗效果影响的研究
Gabriele Tulone,Nicola Pavan,Teresa M Fasciana et al.
Gabriele Tulone et al.
Background: Intravesical Bacillus Calmette-Guérin (BCG) is an established adjuvant therapy for high-risk superficial bladder cancer, though its efficacy varies among patients. Recent interest in the urinary microbiome co...
Elevated creatinine-to-hemoglobin ratio is a novel preoperative marker for worsened survival outcomes in upper tract urothelial carcinoma: analysis from the ROBUUST registry [0.03%]
血清肌酐与血红蛋白比值升高是上尿路尿路上皮癌预后评估的新指标：来自ROBUUST注册数据库的分析
Margaret F Meagher,Clara Cerrato,Mimi V Nguyen et al.
Margaret F Meagher et al.
Background: To determine the utility of creatinine-to-hemoglobin (Cr:Hgb) ratio, as a predictor of survival outcomes in upper tract urothelial carcinoma (UTUC). ...
Multicenter Study
Minerva urology and nephrology. 2025 Dec;77(6):795-802. DOI:10.23736/S2724-6051.25.05498-9 2025
YAU-RCC insights from EAU25 congress: shaping the future through biomarkers and technology [0.03%]
EAU25会议上的YAU-RCC见解：通过生物标志物和技术塑造未来
Daniele Amparore,Savio D Pandolfo,Cristian Fiori et al.
Daniele Amparore et al.
YAU-RCC Insights from the SYNERGY 2025 meeting: key drivers of localized renal cell carcinoma management [0.03%]
SYNERGY 2025会议关于局部肾细胞癌管理关键驱动因素的YAU-RCC见解
Savio D Pandolfo,Ciro Imbimbo,Riccardo Campi et al.
Savio D Pandolfo et al.
SYNERGY in uro-oncology: navigating decisions in low-risk prostate cancer [0.03%]
前列腺低危患者的治疗选择：泌尿生殖系统肿瘤协同研究项目（SYNERGY）
Fabio Zattoni,Savio D Pandolfo,Gianluca Spena et al.
Fabio Zattoni et al.
SYNERGY in uro-oncology: multidisciplinary strategies for organ preservation beyond BCG failure [0.03%]
协同作战泌尿肿瘤学：膀胱内药BCG无效应如何采取多学科策略进行器官保护
Benjamin Pradere,Laura Mertens,Savio D Pandolfo et al.
Benjamin Pradere et al.